Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Reigner

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 1996
Factors influencing elimination and distribution of fleroxacin: metaanalysis of individual data from 10 pharmacokinetic studiesB G Reigner, H A Welker
International Journal of Clinical Pharmacology and Therapeutics|November 14, 1997
Exploring clinical study design by computer simulation based on pharmacokinetic/pharmacodynamic modellingR Gieschke, B G Reigner, J L Steimer
Therapie|March 1, 1988
[Pharmacokinetic bases of bioavailability studies]W Couet, B G Reigner, J B Fourtillan
Journal of Chromatography|November 30, 1990
Simultaneous assay of pentachlorophenol and its metabolite, tetrachlorohydroquinone, by gas chromatography without derivatizationB G Reigner, J F Rigod, T N Tozer
Pharmaceutical Research|August 1, 1992
Disposition, bioavailability, and serum protein binding of pentachlorophenol in the B6C3F1 mouseB G Reigner, J F Rigod, T N Tozer
Human & Experimental Toxicology|January 1, 1992
Assessment of pentachlorophenol exposure in humans using the clearance conceptB G Reigner, F Y Bois, T N Tozer
Human & Experimental Toxicology|May 1, 1993
Pentachlorophenol carcinogenicity: extrapolation of risk from mice to humansB G Reigner, F Y Bois, T N Tozer
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1991
Theoretical model for both saturable rate and extent of absorption: simulations of cefatrizine dataW R Couet, B G Reigner, J P Guedes, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1991
Pentachlorophenol toxicokinetics after intravenous and oral administration to ratB G Reigner, R A Gungon, M K Hoag, et al.
Pathologie-Biologie|May 1, 1988
[Pharmacokinetics of cefatrizine administered in repeated doses]W Couet, B G Reigner, M A Lefebvre, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|March 1, 1996
Factors influencing elimination and distribution of fleroxacin: metaanalysis of individual data from 10 pharmacokinetic studiesB G Reigner, H A Welker
International Journal of Clinical Pharmacology and Therapeutics|November 14, 1997
Exploring clinical study design by computer simulation based on pharmacokinetic/pharmacodynamic modellingR Gieschke, B G Reigner, J L Steimer
Therapie|March 1, 1988
[Pharmacokinetic bases of bioavailability studies]W Couet, B G Reigner, J B Fourtillan
Journal of Chromatography|November 30, 1990
Simultaneous assay of pentachlorophenol and its metabolite, tetrachlorohydroquinone, by gas chromatography without derivatizationB G Reigner, J F Rigod, T N Tozer
Pharmaceutical Research|August 1, 1992
Disposition, bioavailability, and serum protein binding of pentachlorophenol in the B6C3F1 mouseB G Reigner, J F Rigod, T N Tozer
Human & Experimental Toxicology|January 1, 1992
Assessment of pentachlorophenol exposure in humans using the clearance conceptB G Reigner, F Y Bois, T N Tozer
Human & Experimental Toxicology|May 1, 1993
Pentachlorophenol carcinogenicity: extrapolation of risk from mice to humansB G Reigner, F Y Bois, T N Tozer
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1991
Theoretical model for both saturable rate and extent of absorption: simulations of cefatrizine dataW R Couet, B G Reigner, J P Guedes, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1991
Pentachlorophenol toxicokinetics after intravenous and oral administration to ratB G Reigner, R A Gungon, M K Hoag, et al.
Pathologie-Biologie|May 1, 1988
[Pharmacokinetics of cefatrizine administered in repeated doses]W Couet, B G Reigner, M A Lefebvre, et al.
Pageof 2